K Ito

No ORCID on file · 7 papers in corpus
article 2005
Journal of Clinical Oncology ·doi:10.1200/jco.2005.23.16_suppl.5050

5050 Background: Epithelial ovarian cancer (EOC) can be subdivided into five major histologic types (Serous(SC), Mucinous(MC), Endometrioid(EC), Clear cell(CC), Undifferentiated (UC)). Among them, CC generally has a poor response to combina…

article 1998
European journal of cancer (Oxford, England : 1990) ·doi:10.1016/s0959-8049(97)10079-x

In this study clinical studies were conducted on galactosyltransferase associated with tumour (GAT) as a newly developed marker of ovarian cancers. The positive rates of GAT with a cut-off value of 16 U/ml (which corresponds to the mean + 2…

article 1994
Gan to kagaku ryoho. Cancer & chemotherapy

We examined GAT, a newly developed tumor marker, in serum samples collected from 1,503 females in six institutions: 387 healthy females, 1,052 patients with gynecological diseases including 311 ovarian cancers, and 64 with nongynecological …

article 1994
Gan to kagaku ryoho. Cancer & chemotherapy

Serum samples from patients with benign or malignant diseases were measured for the newly developed tumor markers CA54/61 and CA602 with the respective EIA kits for assessment of their utility as tumor markers. A total of 5236 patients were…

article 1994
Nihon Sanka Fujinka Gakkai zasshi

UNLABELLED: CA125 has been regarded as a marker for hyperplastic conditions, such as endometriosis or infectious peritonitis. A high serum CA125 level should therefore be carefully evaluated clinically. We measured CA125 levels in sera and …

article 1993
Gan to kagaku ryoho. Cancer & chemotherapy

Galactosyltransferase Associated with Tumor (GAT) was clinically studied in cases of ovarian cancer. When two cut-off levels of GAT were compared, the cut-off level of 16 U/ml (which corresponds to mean + 2SD among healthy females) was foun…

article 1981